Clinical trials
Phase 3 trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5,536 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 37 |
| 2001 | 57 |
| 2002 | 66 |
| 2003 | 95 |
| 2004 | 127 |
| 2005 | 139 |
| 2006 | 177 |
| 2007 | 200 |
| 2008 | 232 |
| 2009 | 218 |
| 2010 | 210 |
| 2011 | 227 |
| 2012 | 220 |
| 2013 | 223 |
| 2014 | 213 |
| 2015 | 244 |
| 2016 | 211 |
| 2017 | 249 |
| 2018 | 261 |
| 2019 | 264 |
| 2020 | 258 |
| 2021 | 307 |
| 2022 | 259 |
| 2023 | 251 |
| 2024 | 262 |
| 2025 | 262 |
| 2026 | 153 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,279 |
| Active, not recruiting | 681 |
| Terminated | 651 |
| Recruiting | 596 |
| Unknown status | 244 |
| Enrolling by invitation | 31 |
| Not yet recruiting | 27 |
| Withdrawn | 26 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 308 |
| Novartis Pharmaceuticals | 303 |
| AstraZeneca | 239 |
| Pfizer | 169 |
| Sanofi | 166 |
| Eli Lilly and Company | 164 |
| Bristol-Myers Squibb | 155 |
| GlaxoSmithKline | 150 |
| Boehringer Ingelheim | 119 |
| Merck Sharp & Dohme LLC | 115 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 227 |
| Breast Neoplasms | 216 |
| Diabetes Mellitus, Type 2 | 151 |
| Neoplasms | 129 |
| Neoplasm Metastasis | 111 |
| Multiple Myeloma | 90 |
| Prostatic Neoplasms | 81 |
| Diabetes Mellitus | 79 |
| Colorectal Neoplasms | 78 |
| Pulmonary Disease, Chronic Obstructive | 77 |
Trials
Showing 1 to 25 of 5,536. Each trial links to its page on Pharma Observatory.
5,436 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.